Mahoney Stephen F.
SEC insider (Form 3/4/5 filer). CIK 0001741389. President and CEO at Viridian Therapeutics, Inc.\DE (VRDN). 8 reported Form 4/5 transactions since Sep 2024; latest on Mar 3, 2026. Located in WALTHAM, MA.
Companies Mahoney Stephen F. has filed insider reports for
- Viridian Therapeutics, Inc.\DE (VRDN): Officer, President and CEO
Mahoney Stephen F.
CIK: 0001741389
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Viridian Therapeutics, Inc.\DE
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Mar 3, 2026VRDN
Viridian Therapeutics, Inc.\DE
Tax PaymentDirect7.4K shares at avg. $30.19$224K - Mar 3, 2026VRDN
Viridian Therapeutics, Inc.\DE
ExerciseDirect18.4K shares- - Mar 3, 2026VRDN
Viridian Therapeutics, Inc.\DE
Tax PaymentDirect7.6K shares at avg. $29.32$224K - Mar 2, 2026VRDN
Viridian Therapeutics, Inc.\DE
AwardDirectRestricted Stock Units
111.9K shares- - Mar 2, 2026VRDN
Viridian Therapeutics, Inc.\DE
AwardDirectStock Option (Right to Buy)
559.6K shares- - Mar 3, 2025VRDN
Viridian Therapeutics, Inc.\DE
AwardDirectRestricted Stock Units
73.4K shares- - Mar 3, 2025VRDN
Viridian Therapeutics, Inc.\DE
AwardDirectStock Option (Right to Buy)
440.6K shares- - Sep 27, 2024VRDN
Viridian Therapeutics, Inc.\DE
PurchaseDirect21.4K shares at avg. $23.33$499K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 3, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Tax Payment | 7,408 | $30.19 | $223,648 | Direct |
| Mar 3, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Exercise | 18,357 | - | $0 | Direct |
| Mar 3, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Tax Payment | 7,627 | $29.32 | $223,624 | Direct |
| Mar 2, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Award Restricted Stock Units | 111,900 | - | - | Direct |
| Mar 2, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Award Stock Option (Right to Buy) | 559,600 | - | - | Direct |
| Mar 3, 2025 | VRDN Viridian Therapeutics, Inc.\DE | Award Restricted Stock Units | 73,428 | - | - | Direct |
| Mar 3, 2025 | VRDN Viridian Therapeutics, Inc.\DE | Award Stock Option (Right to Buy) | 440,565 | - | - | Direct |
| Sep 27, 2024 | VRDN Viridian Therapeutics, Inc.\DE | Purchase | 21,400 | $23.33 | $499,262 | Direct |
1-8 of 8 transactions